Matches in Wikidata for { <http://www.wikidata.org/entity/Q90097417> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q90097417 description "article scientifique publié en 2018" @default.
- Q90097417 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q90097417 description "scientific article published on 07 July 2018" @default.
- Q90097417 description "wetenschappelijk artikel" @default.
- Q90097417 description "наукова стаття, опублікована в липні 2018" @default.
- Q90097417 name "Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?" @default.
- Q90097417 name "Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?" @default.
- Q90097417 type Item @default.
- Q90097417 label "Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?" @default.
- Q90097417 label "Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?" @default.
- Q90097417 prefLabel "Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?" @default.
- Q90097417 prefLabel "Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?" @default.
- Q90097417 P1433 Q90097417-99FC1B76-27EC-47BB-B0B5-0FA673A6161F @default.
- Q90097417 P1476 Q90097417-60209378-CCB9-45AB-B9FE-C34B92151EE1 @default.
- Q90097417 P2093 Q90097417-1AD40D7F-7B62-4426-B60D-D56335E17BD4 @default.
- Q90097417 P2093 Q90097417-2DD964C6-B521-422A-8257-B40FCD80D127 @default.
- Q90097417 P2093 Q90097417-5F927190-AA0E-4C29-861C-5C6EAE520F37 @default.
- Q90097417 P2093 Q90097417-B22BD130-AF2D-4350-B8F3-9BFBB50A006A @default.
- Q90097417 P2093 Q90097417-BB43108D-E8BD-4457-B088-DAF05B0C03E8 @default.
- Q90097417 P2093 Q90097417-DCD1F227-711C-44EA-BF07-447202B1A86F @default.
- Q90097417 P304 Q90097417-29C48CA5-FE9F-4857-8ED1-AD1C5065D424 @default.
- Q90097417 P31 Q90097417-EBDFAEA1-82B9-47C6-AACF-21AB5412A50D @default.
- Q90097417 P356 Q90097417-7B77BFA1-8CCA-40E2-B55E-07AE6537D7D4 @default.
- Q90097417 P433 Q90097417-0E1F62C6-B383-4D4E-A947-1F2144633A9A @default.
- Q90097417 P478 Q90097417-150359E0-5A79-4CB1-BD6D-E093F6149045 @default.
- Q90097417 P577 Q90097417-D4767C29-7CC5-4108-9201-0B6404A53717 @default.
- Q90097417 P698 Q90097417-65F39E6B-62E2-4252-8155-3396729826A7 @default.
- Q90097417 P921 Q90097417-05590F0C-B361-4798-BEBE-A6BC615DC230 @default.
- Q90097417 P356 J.REC.2018.03.024 @default.
- Q90097417 P698 31007166 @default.
- Q90097417 P1433 Q2467119 @default.
- Q90097417 P1476 "Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?" @default.
- Q90097417 P2093 "Ferran Pérez-Alcántara" @default.
- Q90097417 P2093 "Iñaki Lekuona" @default.
- Q90097417 P2093 "José Luis Zamorano" @default.
- Q90097417 P2093 "José Manuel Rodríguez" @default.
- Q90097417 P2093 "Manuel Anguita" @default.
- Q90097417 P2093 "Paloma Barja de Soroa" @default.
- Q90097417 P304 "398-406" @default.
- Q90097417 P31 Q13442814 @default.
- Q90097417 P356 "10.1016/J.REC.2018.03.024" @default.
- Q90097417 P433 "5" @default.
- Q90097417 P478 "72" @default.
- Q90097417 P577 "2018-07-07T00:00:00Z" @default.
- Q90097417 P698 "31007166" @default.
- Q90097417 P921 Q815819 @default.